March 2026
1. BOUSSINGAULT L, Mtimet L, Suppa M
   Noninvasive skin imaging of melanocytic and nonmelanocytic tumours: recent findings.
   Curr Opin Oncol. 2026;38:95-101.
   

   >> Share

   
   
2. ABBOUD S, Romano L, Langouo Fontsa M
   Melanoma in adolescents and young adults: special considerations.
   Curr Opin Oncol. 2026;38:89-94.
   

   >> Share

   
   March 2025
3. MARTIN FUENTES A
   The role of the microbiome in skin cancer development and treatment.
   Curr Opin Oncol. 2025;37:121-125.
   

   >> Share

   
   January 2025
4. MOUNA O, Hanssens C, Meyers M, Langouo M, et al
   Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy.
   Curr Opin Oncol. 2025 Jan 16. doi: 10.1097/CCO.0000000000001118.
   

   >> Share

   
   December 2024
5. MEYERS M, Mouna O, Langouo M
   Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?
   Curr Opin Oncol. 2024 Dec 30. doi: 10.1097/CCO.0000000000001119.
   

   >> Share

   
   March 2024
6. PADONOU F, Vanhulst T, Langouo-Fontsa MD
   Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?
   Curr Opin Oncol. 2024;36:63-68.
   

   >> Share

   
   January 2024
7. BENHIMA N, Belbaraka R, Fontsa ML
   Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence.
   Curr Opin Oncol. 2024 Jan 3. doi: 10.1097/CCO.0000000000001014.
   

   >> Share

   
   September 2023
8. KINDT N, Kotecki N, Awada A
   Preclinical models to understand the biology and to discover new targets in brain metastases.
   Curr Opin Oncol. 2023;35:436-440.
   

   >> Share

   
   July 2023
9. SAUDE-CONDE R, Nguyen D, Hendlisz A
   Immunotherapies in non-metastatic gastrointestinal cancers.
   Curr Opin Oncol. 2023;35:334-346.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share